Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:1527-1531
Published online before print September 6, 2005, doi: 10.1161/CIRCULATIONAHA.105.548487
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/11/1527    most recent
CIRCULATIONAHA.105.548487v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darbar, D.
Right arrow Articles by Roden, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darbar, D.
Right arrow Articles by Roden, D. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LITHIUM CHLORIDE
*LITHIUM COMPOUNDS
Related Collections
Right arrow Ion channels/membrane transport
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrowRelated Article

(Circulation. 2005;112:1527-1531.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Unmasking of Brugada Syndrome by Lithium

Dawood Darbar, MD; Tao Yang, MD, PhD; Keith Churchwell, MD; Arthur A.M. Wilde, MD, PhD; Dan M. Roden, MD

From the Divisions of Clinical Pharmacology (D.D., T.Y., D.M.R.) and Cardiovascular Medicine (D.D., K.C., D.M.R.), Vanderbilt University School of Medicine, Nashville, Tenn, and Cardiology Department (A.A.M.W.), Academic Medical Center, Amsterdam, the Netherlands.

Reprint requests to Dawood Darbar, MD, Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Room 383, Preston Research Bldg, Nashville, TN 37232-6602. E-mail dawood.darbar{at}vanderbilt.edu

Received March 10, 2005; revision received June 7, 2005; accepted June 21, 2005.

Background— The characteristic ECG pattern of ST-segment elevation in V1 and V2 in the Brugada syndrome is dynamic; it is often intermittently present in affected individuals and can be unmasked by sodium channel blockers, including antiarrhythmic drugs and tricyclic antidepressants. We report here 2 patients who developed the Brugada ECG pattern after administration of lithium, a commonly used drug not previously reported to block cardiac sodium channels.

Methods and Results— Lithium induced transient ST-segment elevation (type 1 Brugada pattern) in right precordial leads at therapeutic concentrations in 2 patients with bipolar disorder. Lithium withdrawal in the patients resulted in reversion to type 2 or 3 Brugada patterns or resolution of ST-T abnormalities. In Chinese hamster ovary cells transfected with SCN5A, which encodes the cardiac sodium channel, lithium chloride caused concentration-dependent block of peak INa at levels well below the therapeutic range (IC50 of 6.8±0.4 µmol/L).

Conclusions— The widely used drug lithium is a potent blocker of cardiac sodium channels and may unmask patients with the Brugada syndrome.


Key Words: Brugada syndrome • lithium • drugs • genetics • ion channels


Related Article:

Issue Highlights
Circulation 2005 112: 1519. [Extract] [Full Text]



This article has been cited by other articles:


Home page
EuropaceHome page
Y. G. Yap, E. R. Behr, and A. J. Camm
Drug-induced Brugada syndrome
Europace, August 1, 2009; 11(8): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
C. LASKE, S. R. SOEKADAR, R. LASZLO, and C. PLEWNIA
Brugada Syndrome in a Patient Treated With Lithium
Am J Psychiatry, September 1, 2007; 164(9): 1440 - 1441.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. Veltmann, R. Schimpf, C. Echternach, L. Eckardt, J. Kuschyk, F. Streitner, S. Spehl, M. Borggrefe, and C. Wolpert
A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification
Eur. Heart J., November 1, 2006; 27(21): 2544 - 2552.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. I. Keller, H. Huang, J. Zhao, R. Frank, V. Suarez, E. Delacretaz, M. Brink, S. Osswald, N. Schwick, and M. Chahine
A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation
Cardiovasc Res, June 1, 2006; 70(3): 521 - 529.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. R. Josephson, W. J. Lederer, H. A. Hartmann, D. Darbar, T. Yang, D. M. Roden, K. Churchwell, and A. A.M. Wilde
Letter Regarding Article by Darbar et al, "Unmasking of Brugada Syndrome by Lithium"
Circulation, March 14, 2006; 113(10): e408 - e408.
[Full Text] [PDF]